CryoPort (NASDAQ:CYRX) Stock Passes Above 200-Day Moving Average - Time to Sell?

Key Points

• CryoPort shares recently passed above their 200‑day moving average, trading around $10.59 versus the 200‑day average of $9.31 and rising as high as $10.60.
• Analysts have a consensus of “Moderate Buy” with an average price target of $13.31 (seven Buy, one Hold, one Sell); Needham raised its target to $13 and Craig Hallum initiated coverage with a $15 Buy target.
• The company reported quarterly EPS of -$0.21 (missing estimates by $0.02) while beating revenue expectations at $45.45M, and insiders have sold about 59,939 shares (~$471k) in the past 90 days, signaling some insider selling pressure.

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $9.31 and traded as high as $10.60. CryoPort shares last traded at $10.59, with a volume of 243,936 shares traded.

Wall Street Analyst Weigh In

Several research analysts have commented on CYRX shares. Needham & Company LLC lifted their price objective on shares of CryoPort from $12.00 to $13.00 and gave the stock a "buy" rating in a research note on Wednesday, March 4th. Wall Street Zen raised shares of CryoPort from a "sell" rating to a "hold" rating in a research note on Saturday. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of CryoPort in a research note on Friday, March 27th. Finally, Craig Hallum assumed coverage on CryoPort in a research note on Monday, March 30th. They issued a "buy" rating and a $15.00 target price on the stock. Seven research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $13.31.

CryoPort Trading Up 4.1%

The business has a fifty day simple moving average of $8.79 and a two-hundred day simple moving average of $9.31. The company has a market cap of $531.62 million, a PE ratio of 8.02 and a beta of 1.68.

CryoPort (NASDAQ:CYRX - Get Free Report) last announced its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.21) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by ($0.02). The firm had revenue of $45.45 million during the quarter, compared to analysts' expectations of $42.92 million. CryoPort had a net margin of 42.35% and a negative return on equity of 8.22%. Equities analysts expect that CryoPort, Inc. will post -0.73 EPS for the current year.

Insider Activity at CryoPort

In related news, insider Mark W. Sawicki sold 3,235 shares of the business's stock in a transaction dated Monday, March 16th. The shares were sold at an average price of $8.00, for a total value of $25,880.00. Following the sale, the insider directly owned 103,697 shares in the company, valued at approximately $829,576. The trade was a 3.03% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Robert Stefanovich sold 38,700 shares of CryoPort stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $7.76, for a total value of $300,312.00. Following the completion of the transaction, the chief financial officer directly owned 255,701 shares of the company's stock, valued at approximately $1,984,239.76. This represents a 13.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 59,939 shares of company stock worth $471,183. Company insiders own 10.00% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in CYRX. LPL Financial LLC boosted its stake in CryoPort by 6.6% during the fourth quarter. LPL Financial LLC now owns 23,306 shares of the company's stock valued at $224,000 after buying an additional 1,433 shares during the period. The Manufacturers Life Insurance Company boosted its stake in CryoPort by 9.4% during the second quarter. The Manufacturers Life Insurance Company now owns 18,178 shares of the company's stock valued at $136,000 after buying an additional 1,557 shares during the period. State of Wyoming boosted its stake in CryoPort by 30.2% during the second quarter. State of Wyoming now owns 14,218 shares of the company's stock valued at $106,000 after buying an additional 3,301 shares during the period. Basepoint Wealth LLC bought a new stake in CryoPort during the fourth quarter valued at $34,000. Finally, BNP Paribas Financial Markets lifted its stake in CryoPort by 55.2% during the third quarter. BNP Paribas Financial Markets now owns 11,880 shares of the company's stock worth $113,000 after purchasing an additional 4,225 shares during the last quarter. Hedge funds and other institutional investors own 92.90% of the company's stock.

CryoPort Company Profile

CryoPort, Inc NASDAQ: CYRX is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort's product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.